GAREM2: A Potential Drug Target and Biomarker (G150946)

Target Name: GAREM2

NCBI ID: G150946

GAREM2

GAREM2: A Potential Drug Target and Biomarker

GAREM2, a gene named for its unique genetic sequence similarity to the protein GAR, has been identified as a potential drug target and biomarker for various diseases. GAR is a transmembrane protein that plays a crucial role in cell signaling pathways, including cell survival, angiogenesis , and inflammation. The GAREM2 gene has been shown to have similar sequence similarities to GAR, leading to its potential involvement in these processes.

GAREM2 and GAR: Diverse but Similar Proteins

GAR (G protein-coupled receptor) is a family of transmembrane proteins that play a broad role in cellular signaling pathways. GARs are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. The GAREM2 gene is missense mutated, which means that a specific amino acid is replaced with an amino acid that alters its function. Despite this genetic variation, GAREM2 and GAR share significant sequence similarities, including a conserved extracellular domain, a transmembrane segment, and a putative transmembrane spacer.

Expression and Localization of GAREM2

GAREM2 is expressed in various tissues and organs, including brain, heart, skeletal muscles, and tissues. It is primarily expressed in the brain, where it is found in the postsynaptic density of neurons. GAREM2 has also been shown to be expressed in other tissues , including heart, placenta, and testes. The protein is also known to be expressed in various cell types, including cancer cells.

GAREM2 Functions as a Negative Regulatory Element

GAREM2 has been shown to play a negative regulatory role in various processes. For example, GAREM2 has been shown to regulate the activity of the transcription factor CREB, which is involved in the transcription of genes involved in stress response, inflammation, and other processes. GAREM2 has been shown to physically interact with CREB and prevent its activation, thereby inhibiting its transcriptional activity.

GAREM2 as a Potential Drug Target

GAREM2's involvement in cellular signaling pathways makes it an attractive target for drug development. The GAREM2 protein has been shown to play a negative regulatory role in various processes, making it a potential drug target for various diseases. For example, GAREM2 has been shown to be involved in the regulation of stress response, and its inhibition has been shown to protect against stress-induced neurodegeneration.

In addition to its potential role in stress response, GAREM2 has also been shown to be involved in the regulation of inflammation. The GAREM2 protein has been shown to play a negative regulatory role in the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾. GAREM2 has also been shown to prevent the production of these cytokines, thereby reducing their pro-inflammatory effects.

GAREM2 as a Biomarker

GAREM2 has also been identified as a potential biomarker for various diseases. For example, GAREM2 has been shown to be involved in the regulation of pain perception, and its levels have been shown to be decreased in individuals with chronic pain. This suggests that GAREM2 may be a potential target for pain medications.

In addition to its potential role in pain perception, GAREM2 has also been shown to be involved in the regulation of neurodegeneration. The GAREM2 protein has been shown to play a negative regulatory role in the production of neurodegenerate proteins, such as beta-amyloid and tau . GAREM2 has also been shown to prevent the production of these proteins, thereby reducing their neurodegenerate effects.

Conclusion

GAREM2 is a gene that has been identified as a potential drug target and biomarker for various diseases due to its unique genetic sequence similarity to the protein GAR. The GAREM2 protein has been shown to play a negative regulatory role in various processes, including stress response, inflammation, and neurodegeneration. Further research is needed to fully understand the role of GAREM2 in these processes and its potential as a drug target

Protein Name: GRB2 Associated Regulator Of MAPK1 Subtype 2

Functions: Probable adapter protein that may provide a link between cell surface epidermal growth factor receptor and the MAPK/ERK signaling pathway

The "GAREM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAREM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets